Who makes Hyeonggaeyeongyo-tang?

Hyeonggaeyeongyo-tang is developed by Kyung Hee University Hospital at Gangdong.

What development phase is Hyeonggaeyeongyo-tang in?

Hyeonggaeyeongyo-tang is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Hyeonggaeyeongyo-tang

Kyung Hee University Hospital at Gangdong · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Hyeonggaeyeongyo-tang
Also known as	Hyenggaelong Granule
Sponsor	Kyung Hee University Hospital at Gangdong
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Hyeonggaeyeongyo-tang CI brief — competitive landscape report
Hyeonggaeyeongyo-tang updates RSS · CI watch RSS
Kyung Hee University Hospital at Gangdong portfolio CI